Vivimed Labs (NSE:VIVIMEDLAB) EV-to-FCF: (As of Jun. 29, 2026)


NSE:VIVIMEDLAB Vivimed Labs Ltd NSE:VIVIMEDLAB
33 GF Score
Price ₹5.71
GF Value ₹2.53
Valuation Significantly Overvalued
! 7 Warning Signs
View Full Analysis

What is Vivimed Labs EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Vivimed Labs's Enterprise Value is ₹3,831.5 Mil. Vivimed Labs's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was ₹0.0 Mil. Therefore, Vivimed Labs's EV-to-FCF for today is .

The historical rank and industry rank for Vivimed Labs's EV-to-FCF or its related term are showing as below:

NSE:VIVIMEDLAB' s EV-to-FCF Range Over the Past 10 Years
Min: -60.99   Med: 0   Max: 0
Current: -60.99

NSE:VIVIMEDLAB's EV-to-FCF is ranked worse than
100% of 559 companies
in the Drug Manufacturers industry
Industry Median: 20.02 vs NSE:VIVIMEDLAB: -60.99

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

As of today (2026-06-29), Vivimed Labs's stock price is ₹5.71. Vivimed Labs's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was ₹-4.210. Therefore, Vivimed Labs's PE Ratio (TTM) for today is At Loss.


Vivimed Labs  (NSE:VIVIMEDLAB) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

Vivimed Labs's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=5.71/-4.210
=At Loss

Vivimed Labs's share price for today is ₹5.71.
Vivimed Labs's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹-4.210.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Vivimed Labs EV-to-FCF Related Terms


Vivimed Labs EV-to-FCF Historical Data

* Premium members only.

The historical data trend for Vivimed Labs's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Vivimed Labs EV-to-FCF Chart

Vivimed Labs Annual Data
Trend Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
EV-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.79 42.36 12.27 -16.04 -59.02

Vivimed Labs Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 -59.02 0.00 0.00 0.00

NSE:VIVIMEDLAB vs ZTS, UTHR: EV-to-FCF Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Vivimed Labs's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Vivimed Labs EV-to-FCF vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Vivimed Labs's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Vivimed Labs's EV-to-FCF falls into.


NSE:VIVIMEDLAB
33GF Score
Vivimed Labs Ltd NSE:VIVIMEDLAB
EV-to-FCF is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Vivimed Labs EV-to-FCF Calculation

Vivimed Labs's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=3831.521/0
=

Vivimed Labs's current Enterprise Value is ₹3,831.5 Mil.
Vivimed Labs's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Is Vivimed Labs (NSE:VIVIMEDLAB) Overvalued in 2026?

Based on GuruFocus' analysis, Vivimed Labs stock appears to be overvalued. The current stock price of ₹5.71 is trading 125.7% above its estimated GF Value™ of ₹2.53. GuruFocus considers Vivimed Labs to be Significantly Overvalued.

Key valuation signals for NSE:VIVIMEDLAB:

  • EV-to-FCF:
  • GF Value™: ₹2.53 vs. price of ₹5.71 (125.7% above fair value)
  • GF Score™: 33/100 with 7 warning signs

No single metric tells the full story. See the NSE:VIVIMEDLAB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Vivimed Labs Business Description

Other Exchanges 532660:India
Address Green Lands, Beside The Plaza Hotel, D.No. 6-3-866/1/G1, 3rd & 4th Floor, GMR Towers, Begumpet, Hyderabad, TG, IND, 500016
Vivimed Labs Ltd is an India-based company that is engaged in the Business of Active pharmaceutical ingredients, Intermediates, Nutraceutical ingredients, CDMO Finished Dosage Formulation, Specialty Chemicals, and Retail Branded Formulation manufacturing. The company has three reportable segments: the Speciality Chemicals Business, the Pharma Business, and others. The majority of revenue is earned through the Pharma business.
33GF Score

Get the complete analysis for NSE:VIVIMEDLAB

EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹5.71
Price
₹2.53
GF Value